| __timestamp | Amphastar Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 40373000 | 504755000 |
| Thursday, January 1, 2015 | 46974000 | 838526000 |
| Friday, January 1, 2016 | 47298000 | 1177697000 |
| Sunday, January 1, 2017 | 50918000 | 1320433000 |
| Monday, January 1, 2018 | 58044000 | 1556200000 |
| Tuesday, January 1, 2019 | 63109000 | 1834800000 |
| Wednesday, January 1, 2020 | 65157000 | 1346000000 |
| Friday, January 1, 2021 | 68920000 | 1824900000 |
| Saturday, January 1, 2022 | 66592000 | 2115900000 |
| Sunday, January 1, 2023 | 80393000 | 2631300000 |
| Monday, January 1, 2024 | 2954400000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, Regeneron Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc. have demonstrated contrasting approaches to SG&A efficiency.
From 2014 to 2023, Regeneron has seen a staggering 420% increase in SG&A expenses, reflecting its aggressive expansion and investment in marketing and administration. In contrast, Amphastar's SG&A expenses grew by approximately 99%, indicating a more conservative growth strategy.
By 2023, Regeneron's SG&A expenses reached over 2.6 billion, dwarfing Amphastar's 80 million. This disparity highlights Regeneron's larger scale and market presence. However, Amphastar's steady growth suggests a focus on sustainable operations.
Understanding these trends provides valuable insights into each company's strategic priorities and market positioning.
Comparing SG&A Expenses: Zoetis Inc. vs Amphastar Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Protagonist Therapeutics, Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Mesoblast Limited Trends and Insights
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Amphastar Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Walgreens Boots Alliance, Inc. and Amphastar Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Axsome Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Perrigo Company plc or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Amphastar Pharmaceuticals, Inc. vs Dynavax Technologies Corporation Trends and Insights
Operational Costs Compared: SG&A Analysis of Amphastar Pharmaceuticals, Inc. and MiMedx Group, Inc.
Breaking Down SG&A Expenses: Amphastar Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.